|
|
|
|
|
|
|
|
|
|
oncology news
....A total of 39 patients (4.0%) had a VUS in a BRCA1 or BRCA2 gene, with little difference between those who underwent multi-gene screening or limited testing. However, among women who underwent multi-gene panel testing, an additional 3.9 percent harbored non-BRCA pathogenic mutations and 10.1 percent had a non-BRCA VUS.....
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.